Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Humana Inc. Revenue & Financial Statements
Humana Inc. reported revenue of $129.7B for the fiscal year ended December 31, 2025, up 10.1% year over year, with net income of $1.2B and diluted EPS of $9.84.
- Company
- Humana Inc. HUM · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 83.1B | 92.9B | 106.4B | 117.8B | 129.7B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | 3.1B | 3.8B | 4.0B | 2.6B | 2.7B |
| Pretax income | 3.4B | 3.6B | 3.3B | — | (47.0M) |
| Net income | 2.9B | 2.8B | 2.5B | 1.2B | 1.2B |
| Diluted EPS | 22.67 | 22.08 | 20.00 | 9.98 | 9.84 |
| EBITDA | 3.8B | 4.5B | 4.9B | 3.5B | 3.4B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.6B | 29.5B | 29.4B | 29.2B | 32.1B | 32.4B | 32.6B | 32.5B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | 1.2B | 1.1B | 728.0M | (543.0M) | 2.0B | 1.1B | 400.0M | (808.0M) |
| Pretax income | 990.0M | 901.0M | 635.0M | — | — | — | — | — |
| Net income | 741.0M | 679.0M | 480.0M | (693.0M) | 1.2B | 545.0M | 195.0M | (776.0M) |
| Diluted EPS | 6.11 | 5.62 | 3.98 | -5.74 | 10.30 | 4.51 | 1.62 | -6.59 |
| EBITDA | 1.5B | 1.4B | 956.0M | (317.0M) | 2.2B | 1.3B | 591.0M | (644.0M) |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2024 | FY2024 | FY2025 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Total assets | — | 46.5B | — | 48.9B | — |
| Current assets | — | 29.8B | — | 32.7B | — |
| Cash & equivalents | — | 2.2B | — | 4.2B | — |
| Total liabilities | — | 30.0B | — | 31.2B | — |
| Current liabilities | — | 16.9B | — | 16.3B | — |
| Long-term debt | — | 11.1B | — | 12.4B | — |
| Total debt | — | 11.1B | — | 12.4B | — |
| Stockholders’ equity | — | 16.4B | — | 17.7B | — |
| Net debt | — | 8.9B | — | 8.2B | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 2.3B | 4.6B | 4.0B | 3.0B | 921.0M |
| Investing cash flow | (6.6B) | (1.0B) | (3.5B) | (3.0B) | 2.3B |
| Financing cash flow | 3.0B | (1.9B) | (856.0M) | (2.5B) | (1.2B) |
| Capital expenditure | 1.3B | 1.1B | 1.0B | 575.0M | 546.0M |
| Free cash flow | 946.0M | 3.5B | 3.0B | 2.4B | 375.0M |
| Dividends paid | 354.0M | 392.0M | 431.0M | 431.0M | 430.0M |
| Stock-based compensation | 180.0M | 216.0M | 175.0M | 207.0M | 241.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every HUM filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.